News summaryFinancial TimesNov 15, 2026, 11:54 PM
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn(摘要待生成)
Loading...
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn(摘要待生成)